Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Le Sourd

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Journal of Hepatocellular Carcinoma|August 31, 2016
Hepatocellular carcinoma in elderly patients: challenges and solutionsAngélique Brunot, Samuel Le Sourd, Marc Pracht, et al.
Bulletin Du Cancer|March 12, 2018
Alexandra Frelau, Marc Pracht, Samuel Le Sourd, et al.
Bulletin Du Cancer|January 1, 2019
Alexandra Frelau, Marc Pracht, Samuel Le Sourd, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 16, 2026
Machine learning models classifiers enable a strong prediction of radioembolization-induced liver disease, and define a new bilirubin threshold for selection of patientsItzel Rivera, Heloïse Bourien, Ewan Morel-Corlu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 22, 2015
Occupational radiation exposure of medical staff performing ⁹⁰Y-loaded microsphere radioembolizationSophie Laffont, Yan Rolland, Valérie Ardisson, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 4, 2017
Gemcitabine as second-line chemotherapy after Folfirinox failure in advanced pancreatic adenocarcinoma: A retrospective studyJuliette Viaud, Clémence Brac, Pascal Artru, et al.
Cancer Nursing|July 22, 2017
Implementation of a Nurse-driven Educational Program Improves Management of Sorafenib's Toxicities in Hepatocellular CarcinomaAngélique Brunot, Florence Le Roy, Samuel Le Sourd, et al.
Cardiovascular and Interventional Radiology|April 29, 2020
Lymphocytes and Neutrophil-to-Lymphocyte Ratio Variations After Selective Internal Radiation Treatment for HCC: A Retrospective Cohort StudyFlorian Estrade, Céline Lescure, Léa Muzellec, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 12, 2016
High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with <sup>90</sup> Y-loaded glass microsphere radioembolizationEtienne Garin, Yan Rolland, Marc Pracht, et al.
Cancer Chemotherapy and Pharmacology|December 6, 2014
Sorafenib use in elderly patients with hepatocellular carcinoma: caution about use of platelet aggregation inhibitorsJulien Edeline, Laurence Crouzet, Samuel Le Sourd, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Journal of Hepatocellular Carcinoma|August 31, 2016
Hepatocellular carcinoma in elderly patients: challenges and solutionsAngélique Brunot, Samuel Le Sourd, Marc Pracht, et al.
Bulletin Du Cancer|March 12, 2018
Alexandra Frelau, Marc Pracht, Samuel Le Sourd, et al.
Bulletin Du Cancer|January 1, 2019
Alexandra Frelau, Marc Pracht, Samuel Le Sourd, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 16, 2026
Machine learning models classifiers enable a strong prediction of radioembolization-induced liver disease, and define a new bilirubin threshold for selection of patientsItzel Rivera, Heloïse Bourien, Ewan Morel-Corlu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 22, 2015
Occupational radiation exposure of medical staff performing ⁹⁰Y-loaded microsphere radioembolizationSophie Laffont, Yan Rolland, Valérie Ardisson, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 4, 2017
Gemcitabine as second-line chemotherapy after Folfirinox failure in advanced pancreatic adenocarcinoma: A retrospective studyJuliette Viaud, Clémence Brac, Pascal Artru, et al.
Cancer Nursing|July 22, 2017
Implementation of a Nurse-driven Educational Program Improves Management of Sorafenib's Toxicities in Hepatocellular CarcinomaAngélique Brunot, Florence Le Roy, Samuel Le Sourd, et al.
Cardiovascular and Interventional Radiology|April 29, 2020
Lymphocytes and Neutrophil-to-Lymphocyte Ratio Variations After Selective Internal Radiation Treatment for HCC: A Retrospective Cohort StudyFlorian Estrade, Céline Lescure, Léa Muzellec, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 12, 2016
High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with <sup>90</sup> Y-loaded glass microsphere radioembolizationEtienne Garin, Yan Rolland, Marc Pracht, et al.
Cancer Chemotherapy and Pharmacology|December 6, 2014
Sorafenib use in elderly patients with hepatocellular carcinoma: caution about use of platelet aggregation inhibitorsJulien Edeline, Laurence Crouzet, Samuel Le Sourd, et al.
Pageof 4